Immunotherapy Could Fill Unmet Need in Leptomeningeal Metastases Immunotherapy Could Fill Unmet Need in Leptomeningeal Metastases

Immunotherapy with pembrolizumab holds promise for improving the generally dismal outlook in patients with leptomeningeal metastases, a phase 2 trial suggests.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news